Genetically-Modified Hematopoietic Stem Cells and their Progeny for Widespread and Efficient Protein Delivery to Diseased Sites: The Case of Lysosomal Storage Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|12|5|381-388

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.12, Iss.5, 2012-10, pp. : 381-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetically-Modified Human Pluripotent Stem Cells: New Hopes for the Understanding and the Treatment of Neurological Diseases?

By  

Current Gene Therapy, Vol. 13, Iss. 2, 2013-04 ,pp. : 111-119

Bentham Science Publishers

Access to resources Recommend Favorite

Genetically Engineered Stem Cells for Therapeutic Gene Delivery

By  

Current Gene Therapy, Vol. 7, Iss. 4, 2007-01 ,pp. : 249-260

Bentham Science Publishers

Access to resources Recommend Favorite

Prospects of Embryonic Stem Cells in Treatment of Hematopoietic Disorders

By  

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 5, 2007-01 ,pp. : 305-317

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment options for lysosomal storage disorders: developing insights

By van Gelder Carin M   Vollebregt Audrey AM   Plug Iris   van der Ploeg Ans T   Reuser Arnold JJ  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2281-2299

Informa Healthcare

Access to resources Recommend Favorite

Current and emerging therapies for the lysosomal storage disorders

By Pastores Gregory M   Barnett Natalie L  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 891-902

Informa Healthcare

Access to resources Recommend Favorite